ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2009

A Novel Role of ZCCHC6 in the Regulation of MMP13 in Experimental Osteoarthritis in Mice

Mohammad Y Ansari1, Nashrah Ahmad2 and Tariq M Haqqi3, 1Anatomy & Neurobiology, Northeast Ohio Medical University, Roostown, OH, 2School of Biomedical Science, Kent State University, kent, OH, 3Anatomy & Neurobiology, Northeast Ohio Medical University, Rootstown, OH

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoarthritis and Joint Biology – Basic Science Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Zinc Finger CCHC Domain Containing Protein 6 (ZCCHC6) or Terminal Uridylyltransferase 7 (TUT7) is a member of terminal uridylyltransferase family that mediate terminal uridylation of mRNA or miRNA modulating their expression, stability and biogenesis. Matrix metalloprotease 13 (MMP13) is one of the key protease responsible for the degradation of cartilage extracellular matrix and plays central role in the pathogenesis of osteoarthritis (OA). In the present study we investigated the effect of ZCCHC6 deletion on the expression of MMP13 in human and mouse chondrocytes in vitro. We used global zcchc6 knockout (zcchc6-/-) mice to determine the role of zcchc6 in OA pathogenesis and the regulation of MMP13 expression in vivo.

Methods: Human chondrocytes were used for ZCCHC6 knockdown and overexpression experiments. The mouse chondrocytes from zcchc6-/- mice and corresponding wild type (zcchc6+/+) littermate were used to determine the expression of MMP13 under pathological conditions (stimulation with IL-1β). The expression of MMP13 mRNA was determined by qPCR using gene specific TaqMan assays and the protein expression levels were determined using Western blotting and ELISA. The zcchc6-/- and the zcchc6+/+ control mice were subjected to destabilization of medial meniscus (DMM) surgery to determine the role of zcchc6 in OA pathogenesis. The extent of damage to mouse joints was determined by OARSI scoring system.

Results: The expression of ZCCHC6 was upregulated in human normal and OA chondrocytes as well as mouse chondrocytes under pathological conditions. Depletion of ZCCHC6 in human normal and OA chondrocytes resulted in decreased expression of MMP13 at mRNA and protein levels in the presence or absence of IL-1β. Overexpression of ZCCHC6 in human OA chondrocytes resulted in increased expression of MMP13. The expression of MMP13 was found to be downregulated in the mouse chondrocytes prepared from zcchc6-/- mice in comparison to zcchc6+/+ littermate. Transfection of zcchc6 in mouse chondrocytes derived from zcchc6-/- mice reversed the expression of MMP13. The severity of DMM-induced OA was significantly low in zcchc6-/- mice compared to zcchc6+/+ mice. Furthermore, the expression of MMP13 in zcchc6-/- mice joints with DMM surgery was significantly low in comparison to zcchc6+/+ mice.

Conclusion: In the present study, we demonstrate a novel role of ZCCHC6 in the regulation of MMP13 expression in human and mouse chondrocytes and cartilage. We show here that zcchc6 deletion has protective effect on the development of OA.


Disclosure: M. Y. Ansari, None; N. Ahmad, None; T. M. Haqqi, None.

To cite this abstract in AMA style:

Ansari MY, Ahmad N, Haqqi TM. A Novel Role of ZCCHC6 in the Regulation of MMP13 in Experimental Osteoarthritis in Mice [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/a-novel-role-of-zcchc6-in-the-regulation-of-mmp13-in-experimental-osteoarthritis-in-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-role-of-zcchc6-in-the-regulation-of-mmp13-in-experimental-osteoarthritis-in-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology